DK0701627T3 - Nukleinsyreanalogafprøvningsmetoder - Google Patents

Nukleinsyreanalogafprøvningsmetoder

Info

Publication number
DK0701627T3
DK0701627T3 DK94916331.5T DK94916331T DK0701627T3 DK 0701627 T3 DK0701627 T3 DK 0701627T3 DK 94916331 T DK94916331 T DK 94916331T DK 0701627 T3 DK0701627 T3 DK 0701627T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
test methods
acid analog
analog test
methods
Prior art date
Application number
DK94916331.5T
Other languages
English (en)
Inventor
Christopher John Stanley
Original Assignee
Pna Diagnostics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pna Diagnostics As filed Critical Pna Diagnostics As
Application granted granted Critical
Publication of DK0701627T3 publication Critical patent/DK0701627T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK94916331.5T 1993-06-02 1994-05-31 Nukleinsyreanalogafprøvningsmetoder DK0701627T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939311386A GB9311386D0 (en) 1993-06-02 1993-06-02 Nucleic acid analogue assay procedures

Publications (1)

Publication Number Publication Date
DK0701627T3 true DK0701627T3 (da) 1997-07-21

Family

ID=10736511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916331.5T DK0701627T3 (da) 1993-06-02 1994-05-31 Nukleinsyreanalogafprøvningsmetoder

Country Status (9)

Country Link
US (1) US5912145A (da)
EP (1) EP0701627B1 (da)
JP (1) JP2842694B2 (da)
AU (1) AU6802994A (da)
DE (1) DE69401661T2 (da)
DK (1) DK0701627T3 (da)
ES (1) ES2098948T3 (da)
GB (1) GB9311386D0 (da)
WO (1) WO1994028171A1 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629178A (en) * 1994-10-28 1997-05-13 Genetics & Ivf Institute Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA)
CA2219891C (en) 1995-05-05 2002-01-29 Applied Biosystems, Llc Methods and reagents for combined pcr amplification and hybridization probing assay
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
US6485901B1 (en) 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
EP2325198A1 (en) 1999-06-01 2011-05-25 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence
US6613517B2 (en) * 2000-01-15 2003-09-02 Genelabs Technologies, Inc. Nucleic acid binding assay and selection method
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
EP1478656B1 (en) 2002-02-01 2009-09-16 Life Technologies Corporation Oligonucleotide compositions with enhanced efficiency
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
US20030211483A1 (en) * 2002-05-09 2003-11-13 Schroeder Benjamin G. Methods for the enrichment of low-abundance polynucleotides
WO2004014314A2 (en) 2002-08-12 2004-02-19 David Kirn Methods and compositions concerning poxviruses and cancer
CN104644627A (zh) 2004-09-14 2015-05-27 科罗拉多大学董事会 基于基因靶向使用布新洛尔的治疗方法
US7794659B2 (en) 2005-03-10 2010-09-14 Gen-Probe Incorporated Signal measuring system having a movable signal measuring device
EP1933857A2 (en) * 2005-09-07 2008-06-25 Jennerex Biotherapeutics ULC Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
ES2345954T3 (es) 2006-05-12 2010-10-06 Cepheid Deteccion de la union de recombinacion de adn.
WO2009016433A2 (en) 2006-09-15 2009-02-05 Ottawa Health Research Institute Oncolytic rhabdovirus
US20100129902A1 (en) 2008-11-24 2010-05-27 Erhard Ralf Schoenbrunner Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
JP5785942B2 (ja) 2009-06-29 2015-09-30 ルミネックス コーポレーション ヘアピンコンフォメーションを有するキメラプライマーおよびその使用法
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
KR101838472B1 (ko) 2009-09-14 2018-03-15 신라젠(주) 종양 용해 백시니아 바이러스 병용 암 치료요법
WO2011070440A2 (en) 2009-12-10 2011-06-16 Ottawa Hospital Research Institute Oncolytic rhabdovirus
ES2587191T3 (es) 2009-12-23 2016-10-21 Arca Biopharma, Inc. Métodos y composiciones para enfermedades y afecciones cardiovasculares
US9919047B2 (en) 2011-01-04 2018-03-20 Sillajen, Inc. Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
EP2683835B1 (en) 2011-03-08 2017-01-11 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
EP2718427B1 (en) 2011-06-08 2017-01-11 Children's Hospital of Eastern Ontario Research Institute Inc. Compositions for glioblastoma treatment
WO2013036799A2 (en) 2011-09-09 2013-03-14 Fred Hutchinson Cancer Research Center Methods and compositions involving nkg2d inhibitors and cancer
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
RU2019107976A (ru) 2013-02-21 2019-08-23 Тёрнстоун Лимитед Партнершип Композиция вакцины
EP3052193B1 (en) 2013-10-03 2018-01-31 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
MA39171A1 (fr) 2014-01-10 2017-07-31 Glaxosmithkline Intellectual Property (No 2) Ltd Dérivés d'hydroxy formamide et leur utilisation
GB201411567D0 (en) * 2014-06-30 2014-08-13 Epistem Ltd Quantification methods
US20180057839A1 (en) 2014-11-26 2018-03-01 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same
EP3574114B1 (en) 2017-01-26 2022-06-29 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
US12140592B2 (en) 2017-06-16 2024-11-12 Oklahoma Medical Research Foundation Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
EP3867645B1 (en) 2018-10-18 2024-06-05 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
US12510539B2 (en) 2018-10-18 2025-12-30 Progentec Diagnostics, Inc. Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
CN113614535B (zh) 2018-10-31 2024-08-16 亚利桑那大学评议会 用于辐射诱导的肺损伤的生物标志物和使用方法
EP4031118B1 (en) 2019-09-16 2026-01-28 The Children's Hospital of Philadelphia Mithramycin analog for the treatment of swi-snf mutant tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
GB9016163D0 (en) * 1990-07-24 1990-09-05 Cemu Bioteknik Chemical method
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
GB9211979D0 (en) * 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues

Also Published As

Publication number Publication date
JPH08510384A (ja) 1996-11-05
AU6802994A (en) 1994-12-20
EP0701627A1 (en) 1996-03-20
US5912145A (en) 1999-06-15
WO1994028171A1 (en) 1994-12-08
GB9311386D0 (en) 1993-07-21
DE69401661T2 (de) 1997-06-12
ES2098948T3 (es) 1997-05-01
EP0701627B1 (en) 1997-01-29
DE69401661D1 (de) 1997-03-13
JP2842694B2 (ja) 1999-01-06

Similar Documents

Publication Publication Date Title
DE69401661D1 (de) Nukleinsaeure-analog testverfahren
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
DE69841895D1 (de) Nukleinsäuretestverfahren
DE69416200D1 (de) Sondenkonstruktion
FI911152A7 (fi) Nukleiinihapposekvenssin amplifikaatiomenetelmät
FI961283A7 (fi) Tehokkaan nukleiinihapposekvensoinnin menetelmiä ja koostumuksia
FI941495A7 (fi) Testiliuska-analyysijärjestelmä
NO960408D0 (no) DNA sekvenseringsenzymer
DK0566751T3 (da) DNA-påvisningsmetode
DE69404652D1 (de) Analysegerät
DK79793D0 (da) Diagnostic test
FI962340L (fi) Nukleiinihappojen suojaaminen ja analyysimenetelmät
DE4496581T1 (de) Nucleinsäure-Sequenzierungsgele
DE69431229D1 (de) Analoges mehrkanaliges Prüfsystem
DK38989D0 (da) Dna-sekvens
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
DE69418841D1 (de) Intelligente Prüfungsstrasse
FI956320L (fi) Kannatinpalkki
FI964657A0 (fi) Geenitestausmenetelmä
NO962493D0 (no) Skumdemper-testapparat
GB9419292D0 (en) Nucleic acid analysis
DE69405158D1 (de) Elektrotauchlack
DE59405241D1 (de) Sauerstoffmessfühler
DE59406694D1 (de) Viruswirksame substanzen
FI940040L (fi) Nonatetraeenihappojohdannainen